A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by Gruppo Italiano MEsotelioma.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Gruppo Italiano MEsotelioma
Information provided by:
Gruppo Italiano MEsotelioma
ClinicalTrials.gov Identifier:
NCT00551252
First received: October 29, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | No date given |